Manisha Samy

Background

About Manisha Samy

I’m a biotech strategist with a Stanford foundation in Biotechnology through the interdisciplinary Science, Technology & Society (STS) program, driven by a deep commitment to advancing transformative healthcare solutions. Across more than a decade in the industry, I’ve operated at the intersection of science, strategy, and innovation — as a buy-side biotech analyst managing over $2B in AUM, as a founder advising companies in regenerative medicine and gene editing, and as a venture investor guiding early-stage biotech startups through capital raises and technical diligence. I’ve worked alongside C-suite executives, VCs, and founders to shape bold ideas into viable roadmaps — from scientific pipeline strategy and platform positioning to go-to-market execution. Whether it’s launching a first-in-class genomics ETF, building a consulting firm from the ground up, or leading due diligence on cutting-edge therapeutics, my approach combines systems thinking, deep scientific curiosity, and operational precision. I can bring executive-level support, scientific literacy, and operational insight to a mission-driven team working at the frontiers of innovation in therapeutics, diagnostics, or platform technologies. If you’re building something with high stakes and high impact, let’s connect.